<DOC>
	<DOC>NCT00747058</DOC>
	<brief_summary>The purpose of this study is to determine the safety and tolerability of PF-03864086 in healthy male human volunteers. Determine the pharmacokinetics (calculations of the rate of elimination of PF-03864086 from the body once the compound is ingested).</brief_summary>
	<brief_title>A Study To Investigate The Safety, Toleration And Pharmacokinetics Of Single Oral Doses Of PF-03864086 In Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>healthy male volunteers no drug history no other medication for 28 predose age below 21 years age above 55 years</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>phase 1, human study, healthy volunteers</keyword>
</DOC>